OpenURL Connection Search

Select item for more details and to access through your institution.

The combination treatment regimen of ruxolitinib with low-dose mercaptopurine or cytarabine in frail patients with blast-phase myelofibrosis.
Published in:
British Journal of Haematology, 2017, v. 178, n. 4, p. 645, doi. 10.1111/bjh.14162
By:
- Fominykh, Mikhail;
- Shuvaev, Vasily;
- Martynkevich, Irina;
- Polushkina, Lyubov;
- Udaleva, Vera;
- Abdulkadyrov, Kudrat
Publication type:
Article
ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S387, doi. 10.1016/S2152-2650(21)01880-2
By:
- Gavrilina, Olga;
- Zakurdaeva, Kristina;
- Vasileva, Anastasia;
- Vorobyev, Vladimir;
- Butaev, Lev;
- Dubov, Vitaly;
- Dubov, Sergey;
- Toropova, Inessa;
- Gavrilova, Lubov;
- Popova, Marina;
- Siniaev, Aleksandr;
- Kaplanov, Kamil;
- Petrenko, Andrei;
- Ochirova, Oksana;
- Sveshnikova, Yulia;
- Shuvaev, Vasily;
- Grishunina, Maria;
- Kunst, Mikhail;
- Chabaeva, Yulia;
- Al-Radi, Lyubov
Publication type:
Article
Poster: ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S243, doi. 10.1016/S2152-2650(21)01530-5
By:
- Gavrilina, Olga;
- Zakurdaeva, Kristina;
- Vasileva, Anastasia;
- Vorobyev, Vladimir;
- Butaev, Lev;
- Dubov, Vitaly;
- Dubov, Sergey;
- Toropova, Inessa;
- Gavrilova, Lubov;
- Popova, Marina;
- Siniaev, Aleksandr;
- Kaplanov, Kamil;
- Petrenko, Andrei;
- Ochirova, Oksana;
- Sveshnikova, Yulia;
- Shuvaev, Vasily;
- Grishunina, Maria;
- Kunst, Mikhail;
- Chabaeva, Yulia;
- Al-Radi, Lyubov
Publication type:
Article
ENESTop 192-Weeks Results: Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After Stopping Second-Line Nilotinib.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S288, doi. 10.1016/j.clml.2019.07.233
By:
- Mahon, Francois-Xavier;
- Boquimpani, Carla;
- Takahashi, Naoto;
- Benyamini, Noam;
- Clementino, Nelma Cristina D.;
- Shuvaev, Vasily;
- Lipton, Jeffrey H.;
- Turkina, Anna G.;
- De Paz Arias, Raquel;
- Moiraghi, Beatriz;
- Nicolini, Franck E.;
- Dengler, Jolanta;
- Sacha, Tomasz;
- Kim, Dong-Wook;
- Fellague-Chebra, Rafik;
- Tiwari, Ranjan;
- Bouard, Catherine;
- Hughes, Timothy P.
Publication type:
Article
ENESTop 144-Week Update: Long-Term Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After Stopping Second-Line Nilotinib.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S222, doi. 10.1016/j.clml.2018.07.092
By:
- Hughes, Timothy P.;
- Boquimpani, Carla;
- Takahashi, Naoto;
- Benyamini, Noam;
- Clementino, Nelma Cristina D.;
- Shuvaev, Vasily;
- Merchant, Akil;
- Lipton, Jeffrey H.;
- Turkina, Anna G.;
- De Paz Arias, Raquel;
- Moiraghi, Beatriz;
- Nicolini, Franck E.;
- Dengler, Jolanta;
- Sacha, Tomasz;
- Kim, Dong-Wook;
- Fellague-Chebra, Rafik;
- Acharya, Sandip;
- Chaturvedi, Shalini;
- Bouard, Catherine;
- Mahon, François-Xavier
Publication type:
Article
Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience.
Published in:
Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1138683
By:
- Chitanava, Tamara;
- Matvienko, Iuliia;
- Shuvaev, Vasily;
- Voloshin, Sergey;
- Martynkevich, Irina;
- Vlasova, Yulia;
- Efremova, Elizaveta;
- Mileeva, Ekaterina;
- Pirkhalo, Anna;
- Makarova, Taiana;
- Vlasik, Roman;
- Karyagina, Elena;
- Ilìna, Natalia;
- Medvedeva, Nadezhda;
- Dorofeeva, Natalia;
- Shneider, Tatiana;
- Siordiya, Nadia;
- Kulemina, Olga;
- Sbityakova, Evgenia;
- Lazorko, Natalia
Publication type:
Article
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.
Published in:
Annals of Internal Medicine, 2018, v. 168, n. 7, p. 461, doi. 10.7326/M17-1094
By:
- Mahon, François-Xavier;
- Boquimpani, Carla;
- Kim, Dong-Wook;
- Benyamini, Noam;
- Clementino, Nelma Cristina D.;
- Shuvaev, Vasily;
- Ailawadhi, Sikander;
- Lipton, Jeffrey Howard;
- Turkina, Anna G.;
- De Paz, Raquel;
- Moiraghi, Beatriz;
- Nicolini, Franck E.;
- Dengler, Jolanta;
- Sacha, Tomasz;
- Takahashi, Naoto;
- Fellague-Chebra, Rafik;
- Acharya, Sandip;
- Wong, Stephane;
- Jin, Yu;
- Hughes, Timothy P.
Publication type:
Article
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.
Published in:
2018
By:
- Mahon, François-Xavier;
- Boquimpani, Carla;
- Kim, Dong-Wook;
- Benyamini, Noam;
- Clementino, Nelma Cristina D;
- Shuvaev, Vasily;
- Ailawadhi, Sikander;
- Lipton, Jeffrey Howard;
- Turkina, Anna G;
- De Paz, Raquel;
- Moiraghi, Beatriz;
- Nicolini, Franck E;
- Dengler, Jolanta;
- Sacha, Tomasz;
- Takahashi, Naoto;
- Fellague-Chebra, Rafik;
- Acharya, Sandip;
- Wong, Stephane;
- Jin, Yu;
- Hughes, Timothy P
Publication type:
journal article

Found: 8